甲状腺癌中的铁亡:潜在的机制,有效的治疗点和预测性生物标志物
Yuying Chen1, Gang Pan2, Fan Wu2
1The Fourth Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, Zhejiang 310053, China.
概括
作为细胞死亡途径的铁灭,通过抑制瘤生长来治疗甲状腺癌具有前途. 了解铁亡机理和生物标志物可以导致新的疗法和更好的患者预后.
科学领域:
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
- 生物化学 生化学
背景情况:
- 在全球范围内,甲状腺癌的发病率正在上升.
- 铁亡是一种独特的受调细胞死亡形式,涉及铁依赖性脂质过氧化.
- 新出现的证据将铁亡与甲状腺癌的进展联系起来.
研究的目的:
- 审查铁质亡在甲状腺癌中的作用.
- 阐明甲状腺癌中的铁灭机制,治疗点和预测生物标志物.
- 突出铁灭菌作为潜在的治疗策略和甲状腺癌的预后工具.
主要方法:
- 关于铁亡和甲状腺癌的当前研究的文献综述.
- 对铁灭的分子和形态特征的分析.
- 在甲状腺癌中检查与铁亡相关的基因变异.
主要成果:
- 诱导铁致死有效抑制甲状腺癌细胞的增殖.
- 铁亡阻碍了甲状腺瘤的进展.
- 与ferroptosis相关的基因的改变可能成为甲状腺癌的预后预测因素.
结论:
- 铁亡与甲状腺癌有很大关系.
- 向铁亡提供了一个有前途的治疗途径,用于甲状腺癌的管理.
- 铁亡生物标志物可以使甲状腺癌的预后能够准确地预测.
相关概念视频
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
01:27Transducer Mechanism: Enzyme-Linked Receptors
2.4K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.4K